Inflammation and immunomodulatory therapies influence the relationship between ATP-binding cassette A1 membrane transporter-mediated cholesterol efflux capacity and coronary atherosclerosis in rheumatoid arthritis

By sjmartinez • July 31, 2023

Karpouzas GA, Papotti B, Ormseth SR, Palumbo M, Hernandez E, Adorni MP, Zimetti F, Budoff MJ, Ronda N. Inflammation and immunomodulatory therapies influence the relationship between ATP-binding cassette A1 membrane transporter-mediated cholesterol efflux capacity and coronary atherosclerosis in rheumatoid arthritis. J Transl Autoimmun. 2023 Jul 18;7:100209. doi: 10.1016/j.jtauto.2023.100209. PMID: 37520890; PMCID: PMC10371792.

Tags: ABCA1, Cardiology/Epi, Cardiovascular events, Cholesterol efflux capacity, Coronary Atherosclerosis, Corticosteroids, Harbor UCLA, Publications, Rheumatoid arthritis, Rheumatology

Bioresorbable, wireless dual stimulator for peripheral nerve regeneration

Ahn HY, Walters JB, Avila R, Oh S, Seo SG, Kim JU, Park J, Yoo S, Choi YS, Kim TY, Liu J, Yoo JY, Weissleder[...]

Incidence of positive genetic testing among patients referred for cardiac positron emission tomography

Trinh K, Dries A, Boulier K, Wang J. Incidence of positive genetic testing among patients referred for cardiac positron emission tomography. J Med Genet. 2025[...]

Serotonin transporter inhibits antitumor immunity through regulating the intratumoral serotonin axis

Li B, Elsten-Brown J, Li M, Zhu E, Li Z, Chen Y, Kang E, Ma F, Chiang J, Li YR, Zhu Y, Huang J, Fung[...]